PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Ann: PARADIGM REPORTS IND APPLICATION UPDATE, page-60

  1. 1,216 Posts.
    lightbulb Created with Sketch. 1375
    So how long could it possibly take for Paradigm to answer one question and for the FDA to review the answer to one question? It would've been better for PAR to show a greater sense of urgency and say "we plan to submit our response within the fortnight" instead of saying "within the month".

    Hopefully we get some clarification on this and the Fast-Track approval application during the investor call.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.